FZ8-29527-63447
3 vaccinations
5 coded responses
23 check-ins
5 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 301 / GA
- Registered
- 2021-10-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-07
Dose 1 — Moderna
-
2021-10-05
Registered in v-safe
-
2021-10-05
Dose 2 — Moderna
-
2021-10-05
Survey response — day 0, dose 2MedDRA: No adverse event — Feeling: GoodFree text:MedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaFree text: It was all very short lived about 15 hours after I got the shot.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-07
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-11-16
-
2022-01-06
Survey response — 3 months, dose 2MedDRA: Diarrhoea, Fatigue, Headache, Oropharyngeal pain, Pain, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fever, sore throat, diarrhea, fatigue, aches and pain, headache.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-06
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-07
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-04-05
Survey response — 6 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with Covid 19 on January 5, 2022MedDRA releases: 2024-11 · check-in free text available
-
2022-04-05
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-06
-
2022-06-20
Dose 3 — Moderna
-
2022-06-26
Survey response — days 1–6 daily, dose 3MedDRA: Fatigue, Headache, Impaired work ability, Loss of personal independence in daily activities — Feeling: Good · Be unable to do your normal daily activitiesFree text: I was unable to do my normal things/work. This is one week after my 3rd vaccination. I felt fatigued tired and had a headache starting about three hours after the shot and lasting thru Tuesday, Wednesday and Thursday. Returning to normal on Friday.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-27
- 2022-07-06
- 2022-07-11
- 2022-07-18
- 2022-07-25
- 2022-08-01
- 2022-09-20
- 2023-06-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-07 | Moderna | No |
| 2 | 2021-10-05 | Moderna | No |
| 3 | 2022-06-20 | Moderna | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 10 — day 0, dose 2
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): It was all very short lived about 15 hours after I got the shot.
Release 10 — 3 months, dose 2
Symptoms: Fever, sore throat, diarrhea, fatigue, aches and pain, headache.
Release 11 — 6 months, dose 2
Symptoms: Diagnosed with Covid 19 on January 5, 2022
Release 12 — days 1–6 daily, dose 3
Systemic reaction (other): I was unable to do my normal things/work. This is one week after my 3rd vaccination. I felt fatigued tired and had a headache starting about three hours after the shot and lasting thru Tuesday, Wednesday and Thursday. Returning to normal on Friday. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Adverse reaction | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Impaired work ability | · | · | ✓ |
| SRO | Loss of personal independence in daily activities | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release